Supply chain rules not as bad as feared, say German companies
This article was originally published in Scrip
The 15th amendment to Germany’s pharmaceutical law, AMG 15, voted through by the Bundestag in a late night sitting on June 18th, was not as bad as the local industry had feared regarding regulation of the supply chain.
You may also be interested in...
Many changes have come about for the orthopedic innovator Stryker as a result of the pandemic, says group CEO Kevin Lobo. The most important relates to methods of engagement with customers.
To the watching world, China dealt quickly and firmly with COVID-19. Seen from within, the health care system is still adapting to the pandemic, but the government is taking the longer view.
While personal data security must be balanced againt the right to health, winning “trust” is the key to taking AI adoption to the next stage, says a new report focused on the European market.